Kathleen P. Bloch net worth and biography

Kathleen Bloch Biography and Net Worth

CFO of Cytosorbents
Ms. Bloch has more than 20 years of executive financial experience at both public and private companies. From 2008 to 2010, she served as the Chief Operating Officer of PC Group, Inc., where she was hired as CFO in 2007. Prior to this, Ms. Bloch managed the day-to-day operations for The Silverman Group, a real estate and investment company. For ten years prior she was employed by Silver Line Building Products Corporation, a leading privately-held manufacturer of vinyl windows. She served as CFO from 1999 until 2006 when the company was acquired by Andersen Corporation, a leading manufacturer of windows. She holds a Master of Business Administration degree and a Bachelor of Science Accounting degree from LaSalle University.

What is Kathleen P. Bloch's net worth?

The estimated net worth of Kathleen P. Bloch is at least $155,570.00 as of May 25th, 2023. Ms. Bloch owns 47,000 shares of Cytosorbents stock worth more than $155,570 as of June 7th. This net worth approximation does not reflect any other assets that Ms. Bloch may own. Learn More about Kathleen P. Bloch's net worth.

What is Kathleen P. Bloch's salary?

As the CFO of Cytosorbents Co., Ms. Bloch earned a total compensation package of $1,248,680.00 in 2021. Ms. Bloch earned a salary of $370,428.00, a bonus of $91,681.00, stock awards of $444,556.00, options awards of $342,015.00, and no other miscellaneous compensation. Learn More on Kathleen P. Bloch's salary.

How do I contact Kathleen P. Bloch?

The corporate mailing address for Ms. Bloch and other Cytosorbents executives is 7 DEER PARK DRIVE SUITE K, MONMOUTH JUNCTION NJ, 08852. Cytosorbents can also be reached via phone at (732) 329-8885 and via email at [email protected]. Learn More on Kathleen P. Bloch's contact information.

Has Kathleen P. Bloch been buying or selling shares of Cytosorbents?

Within the last three months, Kathleen P. Bloch has bought $40,505.00 in Cytosorbents stock. Most recently, on Thursday, May 25th, Kathleen P. Bloch bought 3,300 shares of Cytosorbents stock. The stock was acquired at an average cost of $2.85 per share, with a total value of $9,405.00. Following the completion of the transaction, the chief financial officer now directly owns 47,000 shares of the company's stock, valued at $133,950. Learn More on Kathleen P. Bloch's trading history.

Who are Cytosorbents' active insiders?

Cytosorbents' insider roster includes Kathleen Bloch (CFO), and Phillip Chan (CEO). Learn More on Cytosorbents' active insiders.

Are insiders buying or selling shares of Cytosorbents?

During the last twelve months, Cytosorbents insiders bought shares 9 times. They purchased a total of 76,671 shares worth more than $141,012.85. The most recent insider tranaction occured on May, 25th when CFO Kathleen P Bloch bought 3,300 shares worth more than $9,405.00. Insiders at Cytosorbents own 8.1% of the company. Learn More about insider trades at Cytosorbents.

Information on this page was last updated on 5/25/2023.

Kathleen P. Bloch Insider Trading History at Cytosorbents

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/25/2023Buy3,300$2.85$9,405.0047,000View SEC Filing Icon  
5/10/2023Buy10,000$3.11$31,100.0043,700View SEC Filing Icon  
6/6/2022Buy8,700$1.90$16,530.0033,700View SEC Filing Icon  
11/23/2021Buy4,000$4.98$19,920.00View SEC Filing Icon  
12/10/2019Buy3,000$3.68$11,040.00View SEC Filing Icon  
11/26/2019Buy1,000$4.27$4,270.00View SEC Filing Icon  
8/16/2019Buy6,500$4.83$31,395.00View SEC Filing Icon  
8/9/2019Buy1,500$5.52$8,280.00View SEC Filing Icon  
5/10/2019Buy3,000$6.49$19,470.00View SEC Filing Icon  
8/28/2018Sell10,000$13.50$135,000.00260,004View SEC Filing Icon  
8/3/2018Sell10,000$12.54$125,400.00260,004View SEC Filing Icon  
5/16/2018Sell12,400$9.00$111,600.00265,704View SEC Filing Icon  
5/14/2018Sell10,000$8.50$85,000.00263,304View SEC Filing Icon  
4/17/2018Sell120$8.25$990.00253,424View SEC Filing Icon  
3/15/2018Sell11,176$8.25$92,202.00261,246View SEC Filing Icon  
3/13/2018Sell1,104$8.25$9,108.00251,174View SEC Filing Icon  
2/21/2018Sell10,000$8.00$80,000.00268,870View SEC Filing Icon  
1/12/2018Sell12,400$7.75$96,100.00241,038View SEC Filing Icon  
1/8/2018Sell32,400$7.30$236,520.00248,638View SEC Filing Icon  
5/15/2017Buy1,000$4.34$4,340.00View SEC Filing Icon  
12/6/2016Buy1,000$4.83$4,830.00122,325View SEC Filing Icon  
9/2/2014Buy65,000$0.23$14,950.00View SEC Filing Icon  
5/20/2014Buy110,000$0.24$26,400.00View SEC Filing Icon  
See Full Table

Kathleen P. Bloch Buying and Selling Activity at Cytosorbents

This chart shows Kathleen P Bloch's buying and selling at Cytosorbents by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cytosorbents Company Overview

Cytosorbents logo
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Princeton, NJ.
Read More

Today's Range

Now: $3.31
Low: $3.20
High: $3.41

50 Day Range

MA: $3.07
Low: $2.37
High: $3.58

2 Week Range

Now: $3.31
Low: $1.03
High: $4.59


52,809 shs

Average Volume

86,576 shs

Market Capitalization

$145.49 million

P/E Ratio


Dividend Yield



Master the Market: Free Stock Analysis + Buy/Sell/Hold Signals!
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Analyze Any Stock Free